NewScen Coast Bio-Pharmaceutical Co., Ltd announced a private placement of 5.40 million shares at a price of CNY 8 per share for the gross proceeds of CNY 43.20 million on September 9, 2022. The transaction includes participation from new investor, Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited. The transaction was approved by Board of directors of the company.